Owing to our experience and our clients’ trust, together we managed to develop several innovative and interesting tools within the scope of market access and systemic solution consulting. We are specializing in:
preparation of solutions acceptable for a payer during the Market Access process (e.g. RSS)
consultancy and exercises related to successful evidence based communication with a payer
reports and solutions related to financing the most expensive diseases
participation in meeting with KOLs and HCS experts
The Pricing and Consulting Department headed by Magdalena Władysiuk, Vice-President of HTA Consulting, and supported by numerous analytical teams offers unique knowledge and extensive experience in the scope of health technology assessment both in Poland and worldwide. By specialising in health technology assessment and value-based pricing we support, advise on and suggest solutions regarding problems occurring in many areas of the health care system.
Experience shows that preparation of the reimbursement application and the reimbursement process are closely related. It requires a broad strategic view on the product, therapies, health problem and the product portfolio. We are not afraid to stand aside, objectively evaluate and propose a strategic solution.
We provide strategic consulting in relation to the HTA report under development and independently from it; on products which are currently reimbursed or will be in the future, for new and existing therapeutic areas.
We offer strategic consulting based on:
Our versatile experience and skilled teams of clinical and economic analysts support the development of comprehensive reports and analyses in the scope of:
Owing to engaging all of our knowledge on the financing system in heath care and the long presence in the industry practising our analytical skills, risk sharing schemes prepared by HTA Consulting:
To date we have prepared more than 50 various types of risk sharing schemes in accordance with the different mechanisms provided in the act on reimbursement. Each of the proposed solutions was custom-made and took into account innovative approach.
Hospitals implement various health technologies (not just drugs but also medical devices, diagnostic or surgical procedures) which require specific financial resources to facilitate not only to the purchase but also maintenance to be available within the framework of contracts concluded with payers.
Such solutions allow for performing analyses of the investment as well as considering the implementation of not only financial tools but also tools used for communications and managing decisions made at the hospital level. Health Technology Assessment (HTA) is a tool used in health care for decision-making, in particular in the scope of implementing new solutions and reimbursement, at various management levels (national, regional, institutional (hospitals)).
HTA is based on the assumption that for a population’s health status to improve it is necessary to maximise effects — mostly clinical effects — within the budget means at hand. The next step towards that improvement is changing the way health care is viewed and practised through prevention and diagnostics with the readiness to face the potentially unfavourable changes. The aim of HTA is also introducing a new quality of processes created by way of performing a systematic, well-documented and comprehensive analysis of consequences (clinical, financial, related to changes in organisation) of implementing new health technologies.
Our one-day training in that scope covers concrete cases and indicates solutions used in leading institutions in other countries and ensures a clear and consistent message on mini-HTA methodology.